PGAM
AZN icon

Princeton Global Asset Management’s AstraZeneca AZN Stock Holding History

Princeton Global Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
+828
New +$156K 0.02% 245
2026
Q1 		– Sell
-829
Closed -$152K – 831
2025
Q4 		$152K Hold
829
– – 0.02% 224
2025
Q3 		$127K Sell
829
-400
-33% -$60.5K 0.02% 234
2025
Q2 		$172K Buy
1,229
+200
+19% +$28K 0.03% 197
2025
Q1 		$151K Sell
1,029
-280
-21% -$40.5K 0.03% 201
2024
Q4 		$171K Sell
1,309
-588
-31% -$82.3K 0.03% 200
2024
Q3 		$295K Sell
1,897
-77
-4% -$12.4K 0.06% 159
2024
Q2 		$308K Buy
1,974
+205
+12% +$30.8K 0.07% 142
2024
Q1 		$240K Sell
1,769
-502
-22% -$66.5K 0.06% 149
2023
Q4 		$306K Hold
2,271
– – 0.08% 135
2023
Q3 		$308K Buy
2,271
+991
+77% +$135K 0.09% 124
2023
Q2 		$183K Sell
1,280
-1,100
-46% -$162K 0.05% 168
2023
Q1 		$330K Buy
2,380
+2
+0.1% +$269 0.1% 132
2022
Q4 		$322K Hold
2,378
– – 0.1% 124
2022
Q3 		$261K Buy
2,378
+1
+0% +$127 0.09% 133
2022
Q2 		$314K Sell
2,377
-250
-10% -$32.8K 0.1% 130
2022
Q1 		$349K Sell
2,627
-599
-19% -$71.8K 0.1% 131
2021
Q4 		$376K Sell
3,226
-63
-2% -$7.41K 0.11% 140
2021
Q3 		$395K Hold
3,289
– – 0.12% 135
2021
Q2 		$394K Sell
3,289
-1,200
-27% -$132K 0.12% 135
2021
Q1 		$446K Buy
4,489
+650
+17% +$65.3K 0.14% 126
2020
Q4 		$384K Sell
3,839
-150
-4% -$15.9K 0.13% 128
2020
Q3 		$437K Buy
3,989
+396
+11% +$44K 0.18% 117
2020
Q2 		$380K Buy
3,593
+3,437
+2,203% +$355K 0.12% 145
2020
Q1 		$14K Hold
156
– – 0.01% 344
2019
Q4 		$16 Buy
+156
New +$14.7K 0.01% 359

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Princeton Global Asset Management's AZN Position: Q2 2026 in Review

Princeton Global Asset Management opened a new position in AstraZeneca (AZN) in Q2 2026: 828 shares worth $155K. The stake represents 0.02% of the portfolio and ranks #245 among its holdings. This is a return to the name: Princeton Global Asset Management previously reported a position in AZN as recently as Q4 2025.

Princeton Global Asset Management first reported a position in AZN in Q4 2019 and has held it in 26 quarters since. The position peaked at $446K in Q1 2021. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Princeton Global Asset Management held 828 shares of AstraZeneca worth $155K as of Q2 2026.
  • AstraZeneca was a new Princeton Global Asset Management position in Q2 2026.
  • AstraZeneca made up 0.02% of Princeton Global Asset Management's portfolio in Q2 2026, its #245 holding.
  • Princeton Global Asset Management first reported a position in AstraZeneca in Q4 2019 and has held it in 26 quarters since.
  • Princeton Global Asset Management's AstraZeneca position peaked at $446K in Q1 2021.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.